Azza A. K. El‐Sheikh

2.3k total citations
77 papers, 1.8k citations indexed

About

Azza A. K. El‐Sheikh is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Azza A. K. El‐Sheikh has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Azza A. K. El‐Sheikh's work include Drug Transport and Resistance Mechanisms (11 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Azza A. K. El‐Sheikh is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Azza A. K. El‐Sheikh collaborates with scholars based in Egypt, Saudi Arabia and Greece. Azza A. K. El‐Sheikh's co-authors include Mohamed A. Morsy, Frans G. M. Rüssel, Jeroen J. M. W. van den Heuvel, Jan J. Koenderink, Rehab Ahmed Rifaai, Mohamed A. El‐Moselhy, Rosalinde Masereeuw, Aly M. Abdelrahman, Ibrahim A. Alhaider and Hany H. Arab and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Azza A. K. El‐Sheikh

74 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azza A. K. El‐Sheikh Egypt 22 447 412 338 274 261 77 1.8k
Radhakrishna Baliga United States 20 721 1.6× 220 0.5× 628 1.9× 174 0.6× 241 0.9× 52 2.3k
P.M. Mrozikiewicz Poland 22 666 1.5× 403 1.0× 93 0.3× 271 1.0× 498 1.9× 128 1.8k
Troels K. Bergmann Denmark 21 457 1.0× 719 1.7× 218 0.6× 234 0.9× 333 1.3× 44 2.1k
R T Dorr United States 23 502 1.1× 727 1.8× 328 1.0× 177 0.6× 126 0.5× 59 1.9k
Jean‐Francois Marier United States 24 539 1.2× 231 0.6× 130 0.4× 165 0.6× 136 0.5× 72 2.0k
Wichittra Tassaneeyakul Thailand 34 578 1.3× 697 1.7× 676 2.0× 416 1.5× 1.3k 5.1× 107 4.0k
Amy Price United Kingdom 6 406 0.9× 200 0.5× 118 0.3× 224 0.8× 302 1.2× 12 1.3k
Agnieszka Seremak‐Mrozikiewicz Poland 20 326 0.7× 112 0.3× 112 0.3× 290 1.1× 88 0.3× 169 1.5k
Plm Jansen Netherlands 17 638 1.4× 321 0.8× 116 0.3× 508 1.9× 247 0.9× 44 2.1k
Ahmet Menteşe Türkiye 28 588 1.3× 133 0.3× 285 0.8× 106 0.4× 87 0.3× 159 2.5k

Countries citing papers authored by Azza A. K. El‐Sheikh

Since Specialization
Citations

This map shows the geographic impact of Azza A. K. El‐Sheikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azza A. K. El‐Sheikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azza A. K. El‐Sheikh more than expected).

Fields of papers citing papers by Azza A. K. El‐Sheikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azza A. K. El‐Sheikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azza A. K. El‐Sheikh. The network helps show where Azza A. K. El‐Sheikh may publish in the future.

Co-authorship network of co-authors of Azza A. K. El‐Sheikh

This figure shows the co-authorship network connecting the top 25 collaborators of Azza A. K. El‐Sheikh. A scholar is included among the top collaborators of Azza A. K. El‐Sheikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azza A. K. El‐Sheikh. Azza A. K. El‐Sheikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Elamin, Bahaeldin K., et al.. (2023). Clinico-Epidemiological Laboratory Findings of COVID- 19 Positive Patients in a Hospital in Saudi Arabia. Infection and Drug Resistance. Volume 16. 4845–4856. 1 indexed citations
4.
Abdel‐Fattah, Maha M., Emad H. M. Hassanein, Ahmed M. Sayed, et al.. (2023). Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats. Pharmaceuticals. 16(4). 533–533. 15 indexed citations
5.
Zaki, Magdi E. A., et al.. (2023). In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing. Journal of Molecular Modeling. 29(3). 70–70. 6 indexed citations
6.
Alaaeldin, Eman, et al.. (2023). Blackberry-Loaded AgNPs Attenuate Hepatic Ischemia/Reperfusion Injury via PI3K/Akt/mTOR Pathway. Metabolites. 13(3). 419–419. 5 indexed citations
7.
Arab, Hany H., Ahmed M. Ashour, Azza A. K. El‐Sheikh, et al.. (2023). Stimulation of Autophagy by Dapagliflozin Mitigates Cadmium-Induced Testicular Dysfunction in Rats: The Role of AMPK/mTOR and SIRT1/Nrf2/HO-1 Pathways. Pharmaceuticals. 16(7). 1006–1006. 15 indexed citations
8.
El‐Tahawy, Nashwa Fathy Gamal, et al.. (2023). Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity. Pharmaceuticals. 16(4). 481–481. 14 indexed citations
9.
Arab, Hany H., Ahmed H. Eid, Ahmed M. Ashour, et al.. (2023). Targeting Autophagy, Apoptosis, and SIRT1/Nrf2 Axis with Topiramate Underlies Its Neuroprotective Effect against Cadmium-Evoked Cognitive Deficits in Rats. Pharmaceuticals. 16(9). 1214–1214. 8 indexed citations
10.
11.
Nazmy, Maiiada, Mahmoud A. Elrehany, Muhamad Mustafa, et al.. (2023). Assessing the Antiproliferative Potential of a Novel Combretastatin A4 Derivative via Modulating Apoptosis, MAPK/ERK and PI3K/AKT Pathways in Human Breast Cancer Cells. Frontiers in Bioscience-Landmark. 28(8). 185–185. 10 indexed citations
12.
13.
El‐Sheikh, Azza A. K., et al.. (2022). Independent Association of 25[OH]D Level on Reduced Glutathione and TNF-α in Patients with Diabetes and/or Hypertension. International Journal of General Medicine. Volume 15. 7065–7075. 1 indexed citations
14.
15.
16.
Ibrahim, Mohamed, et al.. (2018). Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats. Clinical and Experimental Hepatology. 4(3). 175–181. 10 indexed citations
17.
El‐Sheikh, Azza A. K., et al.. (2015). Mechanisms of Thymoquinone Hepatorenal Protection in Methotrexate‐Induced Toxicity in Rats. Mediators of Inflammation. 2015(1). 859383–859383. 120 indexed citations
18.
El‐Sheikh, Azza A. K., Jan J. Koenderink, Alfons C. Wouterse, et al.. (2014). Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Translational research. 164(1). 46–56. 27 indexed citations
19.
El‐Sheikh, Azza A. K., Mohamed A. Morsy, & Abdulla Al‐Taher. (2014). Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage. Life Sciences. 119(1-2). 40–46. 16 indexed citations
20.
El‐Sheikh, Azza A. K., et al.. (1999). Impact of hepatitis C virus infection on schistosomal liver disease.. PubMed. 45(23). 1492–6. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radhakrishna Baliga Breakdown of academic impact, for papers by P.M. Mrozikiewicz Breakdown of academic impact, for papers by Troels K. Bergmann Breakdown of academic impact, for papers by R T Dorr Breakdown of academic impact, for papers by Jean‐Francois Marier Breakdown of academic impact, for papers by Wichittra Tassaneeyakul Breakdown of academic impact, for papers by Amy Price Breakdown of academic impact, for papers by Agnieszka Seremak‐Mrozikiewicz Breakdown of academic impact, for papers by Plm Jansen Breakdown of academic impact, for papers by Ahmet Menteşe
Rankless by CCL
2026